Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8

Schizophrenia Research

Volumn 121, Issue 1-3, 2010, Pages 46-54

  Ellman, Lauren M ^a   Deicken, Raymond F ^b   Vinogradov, Sophia ^b,c   Kremen, William S ^d   Poole, John H ^e   Kern, David M ^h   Tsai, Wei Yann ^f   Schaefer, Catherine A ^g   Brown, Alan S ^f,h  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f Columbia University ^*  (United States)

^g DIVISION OF RESEARCH   (United States)

^h New York State Psychiatric Institute ^*  (United States)

Author keywords

Infection; Obstetric complications; Pregnancy; Proinflammatory cytokines; Schizophrenia; Structural MRI

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; INTERLEUKIN 8; METHADONE; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; CYTOKINE;

ADULT; ARTICLE; BRAIN MALFORMATION; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTORHINAL CORTEX; FEMALE; GESTATIONAL AGE; HUMAN; IMAGE ANALYSIS; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PUTAMEN; RISK FACTOR; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; TEMPORAL CORTEX; BRAIN; COHORT ANALYSIS; ETIOLOGY; GROWTH, DEVELOPMENT AND AGING; IMAGE PROCESSING; METABOLISM; PATHOLOGY; PREGNANCY; PROCEDURES;

ADULT; BRAIN; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-8; MAGNETIC RESONANCE IMAGING; MALE; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA;

EID: 77955057052     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.05.014     Document Type: Article

References (30)

1. Basso B., Gimenez F., Lopez C. IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect. Dis. Obstet. Gynecol. 2005, 13(4):207-211.
2. Borgwardt S.J., Riecher-Rossler A., Dazzan P., Chitnis X., Aston J., Drewe M., et al. Regional gray matter volume abnormalities in the at risk mental state. Biol. Psychiatry 2007, 61(10):1148-1156.
3. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
4. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2004, 161(5):889-895.
5. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort: a population-based modeling study. Arch. Gen. Psychiatry 1998, 55:67-74.
6. Cannon T.D., van Erp T.G., Rosso I.M., Huttunen M., Lonnqvist J., Pirkola T., et al. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 2002, 59(1):35-41.
7. Cannon T.D., Yolken R., Buka S., Torrey E.F. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol. Psychiatry 2008, 64(9):797-802.
8. Collins D.L., Zijdenbos A.P., Kollokian V., Sled J.G., Kabani N.J., Holmes C.J., et al. Design and construction of a realistic digital brain phantom. IEEE Trans. Med. Imaging 1998, 17(3):463-468.
9. Corson P.W., Nopoulos P., Andreasen N.C., Heckel D., Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol. Psychiatry 1999, 46(5):712-720.
10. Dalman C., Allebeck P., Cullberg J., Grunewald C., Koster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch. Gen. Psychiatry 1999, 56(3):234-240.
11. Deicken R.F., Pegues M., Amend D. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr. Res. 1999, 37(3):217-223.
12. Deicken R.F., Eliaz Y., Chosiad L., Feiwell R., Rogers L. Magnetic resonance imaging of the thalamus in male patients with schizophrenia. Schizophr. Res. 2002, 58(2-3):135-144.
13. Ellman L.M., Yolken R.H., Buka S.L., Torrey E.F., Cannon T.D. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol. Psychiatry 2009, 65(12):1040-1047.
14. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 2006, 74:443-477.
15. Fein G., Di Sclafani V., Tanabe J., Cardenas V., Weiner M.W., Jagust W.J., et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000, 55(11):1626-1635.
16. Gur R.E., Keshavan M.S., Lawrie S.M. Deconstructing psychosis with human brain imaging. Schizophr. Bull. 2007, 33(4):921-931.
17. Insel B.J., Schaefer C.A., McKeague I.W., Susser E.S., Brown A.S. Maternal iron deficiency and the risk of schizophrenia in offspring. Arch. Gen. Psychiatry 2008, 65(10):1136-1144.
18. Janeway C.A., Travers P., Walport M., Schlomchik M.J. Immunobiology: The immune system in health and disease 2005, Garland, New York & London. 6th ed.
19. Job D.E., Whalley H.C., Johnstone E.C., Lawrie S.M. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005, 25(4):1023-1030.
20. Kwan R.K., Evans A.C., Pike G.B. MRI simulation-based evaluation of image-processing and classification methods. IEEE Trans. Med. Imaging 1999, 18(11):1085-1097.
21. Laskowska M., Laskowska K., Leszczynska-Gorzelak B., Oleszczuk J. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 2007, 20(7):527-532.
22. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry 2000, 48(8):740-754.
23. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51(11):849-859. (discussion 863-844).
24. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-288.
25. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204(2):313-321.
26. Schaefer C.A., Brown A.S., Wyatt R.J., Kline J., Begg M.D., Bresnahan M.A., et al. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr. Bull. 2000, 26(2):275-286.
27. Schlotz W., Phillips D.I. Fetal origins of mental health: evidence and mechanisms. Brain Behav. Immun. 2009, 23(7):905-916.
28. Susser E.S., Schaefer C.A., Brown A.S., Begg M.D., Wyatt R.J. The design of the prenatal determinants of schizophrenia study. Schizophr. Bull. 2000, 26(2):257-273.
29. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the brain 1988, Thieme Medical Publishers, New York.
30. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 2000, 157(1):16-25.